Phase III Trial Evaluating the Addition of Bevacizumab to Letrozole As First-line Endocrine Therapy for Treatment of Hormone-receptor Positive Advanced Breast Cancer: CALGB 40503 (Alliance)
- Citation:
- J Clin Oncol vol 33 (suppl) abstr 501
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2434
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, CA31946, CA180888, CA180858, CA180820, CA180785
- Corr. Author:
- M. Dickler
- Authors:
- Maura N. Dickler William Thomas Barry Constance T. Cirrincione Matthew James Ellis Mary Ellen Moynahan Federico Innocenti Arti Hurria Hope S. Rugo Diana Lake Olwen M Hahn Bryan P. Schneider Debu Tripathy Eric P. Winer Clifford A. Hudis
- Networks:
- CA136, LAPS-CT018, LAPS-IL057, LAPS-NC007, LAPS-NY016, LAPS-TX035, NY018, TX041
- Study
- CALGB-40503
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: